These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 9427267
1. A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma. Steinberg L, Hassan M, Olmsted L, Sharan V, Stepnick D, Hoppel C, Mugharbil A, Subramanyan S, McGloin B, Mackay W, Strauss M. Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-51-S19-56. PubMed ID: 9427267 [Abstract] [Full Text] [Related]
2. Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase I study. Rosenthal DI, Sinard RJ, Okani O, Corak J, Kavanaugh D, Kamen B, Vuitch FM, Gazdar AF, Griener J, Frenkel EP, Carbone DP. Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-67-S19-71. PubMed ID: 9427270 [Abstract] [Full Text] [Related]
7. The activity of paclitaxel in gastrointestinal tumors. Ajani JA, Ilson DH, Kelsen DP. Semin Oncol; 1995 Oct; 22(5 Suppl 12):46-50; discussion 51-3. PubMed ID: 7481861 [Abstract] [Full Text] [Related]
8. Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: phase I studies. Rosenthal DI, Okani O, Truelson JM, Fathallah-Shaykh H, Vuitch FM, Gazdar AF, Griener J, Landay M, Mendelsohn D, Tourville J, Hamilton L, Orr KY, McWhorter J, Carbone DP. Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-81-S2-84. PubMed ID: 9045344 [Abstract] [Full Text] [Related]
9. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT). Suntharalingam M, Jaboin J, Taylor R, Wolf J, Banglore M, Van Echo D, Ord R. Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515 [Abstract] [Full Text] [Related]
10. Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma. Hanauske AR, Schilling T, Heinrich B, Kau R, Herzog M, Quasthoff S, Bochtler H, Diergarten K, Rastetter J. Semin Oncol; 1995 Dec; 22(6 Suppl 14):35-9. PubMed ID: 8553082 [Abstract] [Full Text] [Related]
11. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390). Forastiere AA, Shank D, Neuberg D, Taylor SG, DeConti RC, Adams G. Cancer; 1998 Jun 01; 82(11):2270-4. PubMed ID: 9610709 [Abstract] [Full Text] [Related]
14. Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer. Hitt R, Paz-Ares L, Hidalgo M, Colomer R, Brandariz A, Peña M, Alvarez-Vicent J, Hornedo J, Cortés-Funes H. Semin Oncol; 1997 Dec 01; 24(6 Suppl 19):S19-20-S19-24. PubMed ID: 9427260 [Abstract] [Full Text] [Related]
15. Treatment of patients with upper gastrointestinal carcinomas. Ajani JA. Semin Oncol; 1997 Dec 01; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271 [Abstract] [Full Text] [Related]
19. A pilot trial of paclitaxel, carboplatin, and concurrent radiotherapy for unresectable squamous cell carcinoma of the head and neck. Conley B, Jacobs M, Suntharalingam M, Zacharski D, Ord RA, Gray W, Aisner J. Semin Oncol; 1997 Feb 01; 24(1 Suppl 2):S2-78-S2-80. PubMed ID: 9045343 [Abstract] [Full Text] [Related]
20. Phase I studies of continuous-infusion paclitaxel given with standard aggressive radiation therapy for locally advanced solid tumors. Rosenthal DI, Close LG, Lucci JA, Schold SC, Truelson J, Fathallah-Skaykh H, Kamen B, Vuitch FM, Gazdar AF, Griener J. Semin Oncol; 1995 Aug 01; 22(4 Suppl 9):13-7. PubMed ID: 7644923 [Abstract] [Full Text] [Related] Page: [Next] [New Search]